GR3005920T3 - - Google Patents

Info

Publication number
GR3005920T3
GR3005920T3 GR920402240T GR920402240T GR3005920T3 GR 3005920 T3 GR3005920 T3 GR 3005920T3 GR 920402240 T GR920402240 T GR 920402240T GR 920402240 T GR920402240 T GR 920402240T GR 3005920 T3 GR3005920 T3 GR 3005920T3
Authority
GR
Greece
Prior art keywords
chem
pharmaceutically
alkyl
compounds
formula
Prior art date
Application number
GR920402240T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005920T3 publication Critical patent/GR3005920T3/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
GR920402240T 1986-10-03 1992-10-08 GR3005920T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91517386A 1986-10-03 1986-10-03

Publications (1)

Publication Number Publication Date
GR3005920T3 true GR3005920T3 (el) 1993-06-07

Family

ID=25435354

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402240T GR3005920T3 (el) 1986-10-03 1992-10-08

Country Status (17)

Country Link
EP (1) EP0266896B1 (el)
JP (1) JPS6396186A (el)
KR (1) KR880005125A (el)
CN (1) CN87107149A (el)
AT (2) ATE79119T1 (el)
BG (1) BG47034A3 (el)
DE (1) DE3780909T2 (el)
DK (1) DK518487A (el)
FI (1) FI874311A (el)
GR (1) GR3005920T3 (el)
HU (1) HU200179B (el)
IE (1) IE872646L (el)
IL (1) IL84051A0 (el)
NZ (1) NZ222015A (el)
PL (1) PL151703B1 (el)
PT (1) PT85850B (el)
ZA (1) ZA877398B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA89829B (en) * 1988-02-05 1990-10-31 Lilly Co Eli Crystalline b-lactam solvate
DE60206365T2 (de) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US20030236243A1 (en) * 2002-05-14 2003-12-25 Shoichet Brian K. Sterically-awkward beta-lactamase inhibitors
US7208486B2 (en) 2003-03-07 2007-04-24 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7235543B2 (en) 2003-03-07 2007-06-26 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CN102144992B (zh) * 2011-03-10 2013-04-10 浙江大学 苯基甘氨酸衍生物制备对金黄色葡萄球菌有抑菌和杀菌活性的抗菌剂的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697515A (en) * 1963-02-18 1972-10-10 Ciba Geigy Corp Process for splitting the 7-n-acyl group from cephalosporin compounds
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
NO155547C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Optisk aktive cefalosporin-analoge og salter derav samt fremgangsmaate for deres fremstilling.
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd 3位置換カルバセフエム化合物
US4673737A (en) * 1985-08-02 1987-06-16 Harvard University 7-acylamino-(or 7-amino)-3-trifluoromethylsulfonyloxy-1-carba(1-dethia)-3-cephem-4-carboxylic acids and esters thereof

Also Published As

Publication number Publication date
KR880005125A (ko) 1988-06-28
AU591811B2 (en) 1989-12-14
ATE79119T1 (de) 1992-08-15
AT388377B (de) 1989-06-12
PT85850A (en) 1987-11-01
FI874311A0 (fi) 1987-10-01
PT85850B (en) 1990-01-12
EP0266896A1 (en) 1988-05-11
IL84051A0 (en) 1988-03-31
BG47034A3 (en) 1990-04-16
DE3780909D1 (en) 1992-09-10
DK518487A (da) 1988-04-04
HU200179B (en) 1990-04-28
EP0266896B1 (en) 1992-08-05
NZ222015A (en) 1989-10-27
IE872646L (en) 1988-04-03
PL268034A1 (en) 1988-09-01
FI874311A (fi) 1988-04-04
CN87107149A (zh) 1988-05-18
ZA877398B (en) 1989-05-30
DK518487D0 (da) 1987-10-02
ATA257587A (de) 1988-11-15
AU7926987A (en) 1988-04-14
JPS6396186A (ja) 1988-04-27
DE3780909T2 (de) 1993-03-04
PL151703B1 (en) 1990-09-28
HUT45053A (en) 1988-05-30

Similar Documents

Publication Publication Date Title
IL64288A0 (en) Improvements relating to 3-aryloxy-3-phenylpropylamines
FI852974L (fi) Nya n-hydroxylgruppen skyddande grupper och framstaellningsfoerfarande foer 3-acylamino-1-hydroxi-2-azetidinoner.
AU563960B2 (en) Substituted 1-hydroxyethyl-triazolyl derivatives
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
FI861506A0 (fi) Foerfarande foer framstaellning av 1,2-ditiolan-3-pentansyra (tioktsyra).
PH23448A (en) Quinoline compounds
ES8706713A1 (es) Un procedimiento para preparar derivados de 4'-desmetil-4-epipodofilotoxina
GR3005920T3 (el)
FI870090A (fi) Laongkedjade alkylresorcinolfosfiter.
UA19160A (uk) Спосіб одержаhhя алкілаhіліhофумарату
FI903967A0 (fi) Nya imidazolderivat.
DE3680725D1 (en) Propanolabkoemmlinge.
DE3681973D1 (de) Dipercarbonsaeuren und bleichmittel.
ES8307812A1 (es) Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo.
ES2001321A6 (es) Procedimiento de obtencion de nuevos derivados de n-(1-piperazinil-acil)l-prolina